/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. AI For Pharma Growth
  2. E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss
E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss

AI For Pharma Growth · Sep 29, 2026

AI is unlocking preventative medicine for pharma. Cancer biologist Rebecca Muff discusses biomarkers, personalized risk, and a new blockbuster model.

Pharma's AI Prevention Research is Happening Now, But Publications Won't Appear Until 2027

The perception that pharma is ignoring preventative medicine is inaccurate. Major research using AI on patient data is currently in progress, but publications aren't expected until late 2026 or 2027 due to the complexities of establishing safety, efficacy, and health equity.

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss thumbnail

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss

AI For Pharma Growth·2 months ago

Next-Generation Blockbuster Drugs Will Target Root Systems Like Inflammation, Not Single Diseases

The next wave of blockbuster therapies will likely be platforms addressing upstream, root-cause systems like chronic inflammation or metabolic health. This approach targets the interconnected nature of the body, influencing multiple diseases simultaneously and shifting away from the traditional single-disease treatment model.

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss thumbnail

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss

AI For Pharma Growth·2 months ago

AI's Real Value is Shifting Medicine from Population Averages to Personalized Patient Risk

The true promise of AI in prevention is enabling a move from generalized to personalized medicine. By sifting through individual electronic health records, AI can identify specific biomarkers and risk factors unique to a person, such as a predisposition for a particular cancer, allowing for precisely targeted interventions.

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss thumbnail

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss

AI For Pharma Growth·2 months ago

Build Clinician and Patient Trust in AI by Proving Success in Small Departments First

To overcome mistrust in AI due to issues like "hallucinations," health systems should avoid large-scale rollouts. Instead, they must build trust by starting small within a single department, proving the concept with a multidisciplinary team, and demonstrating clear wins before scaling across the entire organization.

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss thumbnail

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss

AI For Pharma Growth·2 months ago

GLP-1 Drugs Reveal a 'Prevention Blockbuster' Model By Targeting a Root Cause of Multiple Diseases

GLP-1s offer a blueprint for future blockbuster drugs focused on prevention. By addressing a root metabolic cause linked to obesity, they simultaneously reduce risk for cardiovascular disease, kidney issues, and certain cancers. This multi-disease impact through a single mechanism represents a major commercial and clinical shift.

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss thumbnail

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss

AI For Pharma Growth·2 months ago

True Preventative Medicine Requires Redesigning Hospitals Into 'One-Stop Shops'

The success of preventative medicine hinges on redesigning hospital infrastructure, not just on new technology. To combat patient dropout rates and overcome barriers like travel and time, health systems must evolve into integrated facilities where patients can complete multiple screenings, lab work, and pharmacy pickups in a single visit.

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss thumbnail

E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss

AI For Pharma Growth·2 months ago